Grant: CIHR New Investigator
University of Toronto
$300,000.00
Regulation of invariant Natural Killer T cell development and function
EF 2011-12
Résumé
Invariant Natural Killer T (iNKT) cells are lymphocytes that respond to lipid antigens presented by a molecule named CD1d. Activated iNKT cells rapidly produce large amounts of various soluble mediators that influence ensuing immune responses. Consistent with this, iNKT cells have protective or deleterious functions during the immune responses associated with cancer, inflammation, autoimmunity and infection. Understanding the mechanisms controlling the activation and functional plasticity of these cells is critical and constitutes a major challenge.
iNKT cells express particular T cell receptors (TCRs) that are able to recognize a variety of host- (self) as well as microbe-derived lipids presented by CD1d. Self-lipid recognition is important for the development and activation of these cells, although the relevant CD1d-restricted self-lipids remain poorly defined. Recent work, including from our group, demonstrated that iNKT TCRs recognize CD1d-lipid complexes in a "one-size-fits-all" strategy. Within this conserved strategy, the strength of CD1d-lipid-TCR is seemingly modulated the lipid involved, as well as the TCR composition. Whether consequential affinities of CD1d-lipid-TCR interactions ultimately translate into distinct functional responses is unknown.
Here, we propose to address these questions that are a direct extension of our previous findings. Our specific goals are to identify CD1d-restricted self-lipids and define their regulation of expression in health and disease, as well as their role in iNKT cell development and responses. We will also investigate whether the affinity of CD1d-lipid-TCR interactions translates into differential biological responses from these cells. The results from the proposed studies will shed light on crucial aspects of iNKT cell biology, and will ultimately help the rational design of novel immunotherapies that target iNKT cells.
Programme
CIHR New Investigator
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
241152
Name
Mallevaey Thierry R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
New Investigators A
Projecttitle
Regulation of invariant Natural Killer T cell development and function
Programtype2
Salary Programs
Orgnameinp2
University of Toronto
Cihramount2
$300,000
Cihrequipment2
$0
Programname2
CIHR New Investigator
Keyworddelim
Cd1d; Immunomodulation; Lipid Antigens; Natural Killer T Cells; Nkt Cell Development; Op9-Dl1 System; Tcr Retrogenic Mice
Abstract
Invariant Natural Killer T (iNKT) cells are lymphocytes that respond to lipid antigens presented by a molecule named CD1d. Activated iNKT cells rapidly produce large amounts of various soluble mediators that influence ensuing immune responses. Consistent with this, iNKT cells have protective or deleterious functions during the immune responses associated with cancer, inflammation, autoimmunity and infection. Understanding the mechanisms controlling the activation and functional plasticity of these cells is critical and constitutes a major challenge.
iNKT cells express particular T cell receptors (TCRs) that are able to recognize a variety of host- (self) as well as microbe-derived lipids presented by CD1d. Self-lipid recognition is important for the development and activation of these cells, although the relevant CD1d-restricted self-lipids remain poorly defined. Recent work, including from our group, demonstrated that iNKT TCRs recognize CD1d-lipid complexes in a "one-size-fits-all" strategy. Within this conserved strategy, the strength of CD1d-lipid-TCR is seemingly modulated the lipid involved, as well as the TCR composition. Whether consequential affinities of CD1d-lipid-TCR interactions ultimately translate into distinct functional responses is unknown.
Here, we propose to address these questions that are a direct extension of our previous findings. Our specific goals are to identify CD1d-restricted self-lipids and define their regulation of expression in health and disease, as well as their role in iNKT cell development and responses. We will also investigate whether the affinity of CD1d-lipid-TCR interactions translates into differential biological responses from these cells. The results from the proposed studies will shed light on crucial aspects of iNKT cell biology, and will ultimately help the rational design of novel immunotherapies that target iNKT cells.
Competitiondate
201109
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Mallevaey, Thierry R
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $300,000~ $0~